Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30821401 | 0.98 | NPSR1 (0.52) | NPSR1ALDH1A1L3MBTL1TDP1ATM | |
| SCHEMBL27945332 | 0.91 | ALDH1A1 (0.50) | NPSR1ALDH1A1L3MBTL1TDP1ATM | |
| SCHEMBL27552505 | 0.87 | NPSR1 (0.36) | NPSR1ALDH1A1L3MBTL1TDP1ATM | |
| SCHEMBL28135524 | 0.83 | MEN1 (0.41) | NPSR1ALDH1A1L3MBTL1TDP1ATM | |
| SCHEMBL75885 | 0.82 | NPSR1 (0.64) | NPSR1ALDH1A1L3MBTL1TDP1ATM | |
| SCHEMBL10348556 | 0.82 | NPSR1 (0.64) | NPSR1ALDH1A1L3MBTL1TDP1ATM | |
| SCHEMBL75883 | 0.82 | NPSR1 (0.64) | NPSR1ALDH1A1L3MBTL1TDP1ATM | |
| SCHEMBL4103979 | 0.82 | NPSR1 (0.56) | NPSR1ALDH1A1L3MBTL1TDP1ATM | |
| SCHEMBL28148401 | 0.82 | NPSR1 (0.64) | NPSR1ALDH1A1L3MBTL1TDP1ATM | |
| SCHEMBL10783514 | 0.81 | NPSR1 (0.50) | NPSR1ALDH1A1L3MBTL1TDP1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119264667-A | High expansion rate silicone rubber cold shrink tube | 任丘市恒威通信设备有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-101922376-B | Corrosion resistant insert for a cylinder head | GM GLOBAL TECH OPERATIONS INC | 2013-04-24 | — | — | CN | claimed |
| CN-102796091-A | Substituted oxazolidinone compound and preparation method and application thereof | UNIV PEKING FOUNDER GROUP CO | 2012-11-28 | — | — | CN | claimed |
| US-7704995-B2 | Protein kinase modulators and methods of use | EXELIXIS, INC. (US) | 2010-04-27 | — | — | US | claimed |
| EP-2118064-A2 | 6-AMINOISOQUINOLINE COMPOUNDS USEFUL AS KINASE MODULATORS | AERIE PHARMACEUTICALS, INC. (US) | 2009-11-18 | — | — | EP | claimed |
| WO-2008086269-A2 | 6-AMINOISOQUINOLINE COMPOUNDS USEFUL AS KINASE MODULATORS | AERIE PHARMACEUTICALS, INC. (US) | 2008-07-17 | — | — | WO | claimed |
| US-20060211709-A1 | Protein kinase modulators and methods of use | EXELIXIS, INC. | 2006-09-21 | — | — | US | claimed |
| EP-1501814-A1 | SEMICARBAZIDE DERIVATIVES FOR COMBATING THROMBOEMBOLIC DISEASES | MERCK PATENT GmbH (DE) | 2005-02-02 | — | — | EP | claimed |
| WO-2003093254-A1 | SEMICARBAZIDE DERIVATIVES FOR COMBATING THROMBOEMBOLIC DISEASES | MERCK PATENT GMBH (DE) | 2003-11-13 | — | — | WO | claimed |
| EP-0192242-B1 | SUBSTITUTED AMINOPHENYLUREA DERIVATIVES | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1990-11-07 | — | — | EP | claimed |
| US-4803223-A | ANTITUMOR AGENTS | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1989-02-07 | — | — | US | claimed |
| EP-0187121-B1 | HEAT-CURABLE EPOXY RESIN COMPOSITIONS | CIBA-GEIGY AG (CH) | 1988-07-13 | — | — | EP | claimed |
| US-4645818-A | CONTAINING AN AMIDOARYLUREA | CIBA-GEIGY CORPORATION (US) | 1987-02-24 | — | — | US | claimed |
| EP-0192242-A1 | Substituted aminophenylurea derivatives | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1986-08-27 | — | — | EP | claimed |
| US-4358611-A | FROM A PHENYLHYDRAZINE, A CHLOROFORMATE, PHOSGENE AND A SECONDARY AMINE | SHELL OIL COMPANY (US) | 1982-11-09 | — | — | US | claimed |
| US-3983564-A | Image recording member | CANON KABUSHIKI KAISHA (JA) | 1976-09-28 | — | — | US | claimed |
| US-12559455-B2 | Compound as a UBR box domain ligand | AUTOTAC INC. (KR) | 2026-02-24 | — | — | US | disclosed |
| CN-120005335-A | Perfluororubber composition, preparation method thereof and product | 上海芯密科技股份有限公司 | 2025-05-16 | — | — | CN | disclosed |
| US-3965087-A | Trisazo dye containing a diphenylenesulfone structure | SAKAI CHEMICAL INDUSTRY COMPANY LTD. (JA) | 1976-06-22 | — | — | US | disclosed |
| US-3951941-A | POLYAZODYE | SAKAI CHEMICAL INDUSTRY COMPANY, LIMITED (JA) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211709-A1 | Protein kinase modulators and methods of use | GRK2, MAP4K2, MAPKAPK2 | NPSR1 768/4885ALDH1A1 3298/4885L3MBTL1 2736/4885 |
| US-12559455-B2 | Compound as a UBR box domain ligand | UBR4, UBTF, UBQLN1 | NPSR1 969/4885ALDH1A1 1486/4885L3MBTL1 1436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.